18 related articles for article (PubMed ID: 38565061)
1. Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines.
Soleiman M; Fathi-Roudsari M; Khajeh K; Maghsoudi A
Cancer Invest; 2024 Apr; 42(4):319-332. PubMed ID: 38695671
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Activity of Aaptos suberitoides on Glioblastoma Multiforme Cell Line.
Huda F; Hermawan R; Putri T; Dwiwina RG; Berbudi A; Bashari MH
Asian Pac J Cancer Prev; 2024 May; 25(5):1815-1821. PubMed ID: 38809654
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
Zhou X; Lv L; Tan Y; Zhang Z; Wei S; Xiao S
Brain Res; 2021 Sep; 1766():147515. PubMed ID: 33984327
[TBL] [Abstract][Full Text] [Related]
4. 2,5-Dimethyl Celecoxib Inhibits Proliferation and Cell Cycle and Induces Apoptosis in Glioblastoma by Suppressing CIP2A/PP2A/Akt Signaling Axis.
Gao D; Nyalali AMK; Hou Y; Xu Y; Zhou J; Zhao W; Huang B; Li F
J Mol Neurosci; 2021 Aug; 71(8):1703-1713. PubMed ID: 33400072
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis.
Murphy ÁC; Weyhenmeyer B; Noonan J; Kilbride SM; Schimansky S; Loh KP; Kögel D; Letai AG; Prehn JH; Murphy BM
Apoptosis; 2014 Apr; 19(4):629-42. PubMed ID: 24213561
[TBL] [Abstract][Full Text] [Related]
6. The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma.
Ozyerli-Goknar E; Sur-Erdem I; Seker F; Cingöz A; Kayabolen A; Kahya-Yesil Z; Uyulur F; Gezen M; Tolay N; Erman B; Gönen M; Dunford J; Oppermann U; Bagci-Onder T
Cell Death Dis; 2019 Nov; 10(12):894. PubMed ID: 31772153
[TBL] [Abstract][Full Text] [Related]
7. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
[TBL] [Abstract][Full Text] [Related]
8. DMC-siERCC2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment.
Song M; Wang T; Liu T; Lei T; Teng X; Peng Q; Zhu Q; Chen F; Zhao G; Li K; Qi L
Biomed Pharmacother; 2024 May; 174():116470. PubMed ID: 38565061
[TBL] [Abstract][Full Text] [Related]
9. Overcoming TRAIL Resistance for Glioblastoma Treatment.
Deng L; Zhai X; Liang P; Cui H
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919846
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
